{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:46:54Z","timestamp":1793234814956,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Natural Sciences Funding of China"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.08.165","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:40:00Z","timestamp":1536849600000},"page":"184-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"special_numbering":"C","title":["The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer"],"prefix":"10.1016","volume":"108","author":[{"given":"Lu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siruo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noosheen","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.08.165_bib0005","first-page":"104","article-title":"Colorectal cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2018.08.165_bib0010","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1200\/JCO.2008.20.7050","article-title":"Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial","volume":"27","author":"Tsikitis","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0015","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.08.165_bib0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrclinonc.2014.51","article-title":"Standing the test of time: targeting thymidylate biosynthesis in cancer therapy","volume":"11","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phrs.2013.03.010","article-title":"Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells","volume":"72","author":"Gonz\u00e1lez-Vallinas","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2018.08.165_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.08.165_bib0035","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.08.165_bib0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fmicb.2017.01265","article-title":"Human gut microbiota: toward ecology of disease","volume":"8","author":"Selber-Hnatiw","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","article-title":"The resilience of the intestinal microbiota influences health and disease","volume":"15","author":"Sommer","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0055","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.08.165_bib0060","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"42","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.08.165_bib0065","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.08.165_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2017.03.046","article-title":"Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics","volume":"169","author":"Garc\u00eda-Gonz\u00e1lez","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.08.165_bib0075","first-page":"4109","article-title":"Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice","volume":"46","author":"Natio","year":"1986","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.165_bib0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.2276","article-title":"Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing","volume":"10","author":"Bokulich","year":"2013","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.biopha.2018.08.165_bib0085","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"UPARSE: highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2018.08.165_bib0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communitiesusing 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/nar\/gkt1076","article-title":"Data, information, knowledge and principle: back to metabolism in KEGG","volume":"42","author":"Kanehisa","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2018.08.165_bib0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2018.08.165_bib0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17512433.2018.1414598","article-title":"The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues","volume":"11","author":"Curr\u00f2","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0110","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S0007114513004248","article-title":"Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice","volume":"111","author":"Justino","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2018.08.165_bib0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2017.00455","article-title":"Alteration of gut microbiota and inflammatory Cytokine\/Chemokine profiles in 5-Fluorouracil induced intestinal mucositis","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/19490976.2014.997612","article-title":"Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease","volume":"6","author":"Minamoto","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2018.08.165_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1264\/jsme2.ME14054","article-title":"Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice","volume":"29","author":"Kameyama","year":"2014","journal-title":"Microbes Environ."},{"key":"10.1016\/j.biopha.2018.08.165_bib0130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"45","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.08.165_bib0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chom.2007.06.010","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2018.08.165_bib0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2018.08.165_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/toxsci\/kfw150","article-title":"From the cover: exposure to oral antibiotics induces gut microbiota dysbiosis associated with lipid metabolism dysfunction and low-grade inflammation in mice","volume":"154","author":"Jin","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2018.08.165_bib0150","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3389\/fmicb.2017.02306","article-title":"Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ismej.2012.158","article-title":"Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model","volume":"7","author":"Van den Abbeele","year":"2013","journal-title":"ISME J."},{"key":"10.1016\/j.biopha.2018.08.165_bib0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1440-1681.2009.05335.x","article-title":"Efficacy of butyrate analogues in HT-29 cancer cells","volume":"37","author":"Ooi","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-induced changes in the intestinal microbiota and disease","volume":"22","author":"Becattini","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"October (10)","key":"10.1016\/j.biopha.2018.08.165_bib0170","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1007\/s00204-017-1949-2","article-title":"Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats","volume":"91","author":"Behr","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/19490976.2016.1138197","article-title":"Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice","volume":"2","author":"Grazul","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2018.08.165_bib0180","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2017.03.040","article-title":"Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans","volume":"169","author":"Scott","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.08.165_bib0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.116.309219","article-title":"Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants","volume":"119","author":"Kelly","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.08.165_bib0190","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1099\/ijs.0.041376-0","article-title":"Description of Alloprevotella rava gen. nov., sp. nov., isolated from the human oral cavity, and reclassification of Prevotella tannerae Moore et al. 1994 as Alloprevotella tannerae gen. nov., comb. nov","volume":"63","author":"Downes","year":"2013","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.biopha.2018.08.165_bib0195","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1099\/jmm.0.005801-0","article-title":"Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis","volume":"58","author":"Ohkusa","year":"2009","journal-title":"J. Med. Microbiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218348960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218348960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:36:39Z","timestamp":1777271799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218348960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S0753332218348960"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.165","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}